Skin Cancer Market Updates by 2031
Most skin cancers are locally destructive malignant growth of the skin. They come from the epidermis cells, the skin's superficial layer. The vast majority of these types of skin cancers seldom spread (metastasize) to other areas of the body and become life-threatening, unlike cutaneous malignant melanoma. Typically, diagnosing skin cancer starts with a visual inspection. Monthly self-examinations and annual physician visits are advised by the Skin Cancer Foundation and the American Cancer Society to screen for possible skin cancer. If a suspicious spot is identified, the area will first be examined by the doctor, observing its scale, shape, colour and texture, and any bleeding or scaling. Biopsies and imaging scans are the two most common forms of tests used in diagnosing skin cancer. There are many different types of biopsy, but an excisional biopsy in which the doctor extracts all growth is always enough to treat skin cancer. It is more probable that melanoma and Merkel cell carcinoma will spread. In these cases it is possible to use one of many medical imaging techniques to assess if cancer cells have metastasized to internal organs and bones. Procedures for imaging include: CT scan, X-ray, and MRI.
MARKET DYNAMICS
Factors driving the growth of the skin cancer market are the growing incidence of skin cancer, coupled with increasing awareness about skin cancer. However, the high cost associated with diagnosis and treatment is expected to hamper the growth of the market. Moreover, increasing extensive R&D by market players is anticipated to boost the market growth.
MARKET SCOPE
The "Skin Cancer Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of skin cancer market with detailed market segmentation by cancer type and type. The skin cancer market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in skin cancer market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The skin cancer market is segmented on the basis of cancer type and type. Based on cancer type, the market is segmented as melanoma and non-melanoma. On the basis of type, the market is categorized as diagnosis and therapeutics. The diagnosis type is sub segmented as dermatoscopy, biopsy, genetic tests, and others. Therapeutics segment is further sub segmented as chemotherapy, immunotherapy, targeted therapy, and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the skin cancer market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The skin cancer market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting skin cancer market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the skin cancer market in these regions.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the skin cancer market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The skin cancer market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting skin cancer market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the skin cancer market in these regions.
MARKET PLAYERS
The report covers key developments in the skin cancer market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from skin cancer market are anticipated to have lucrative growth opportunities in the future with the rising demand for skin cancer in the global market. Below mentioned is the list of few companies engaged in the skin cancer market.
The report also includes the profiles of key players in skin cancer market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Abbott Laboratories
- Amgen, Inc.
- Merck & Co., Inc.
- Novartis AG
- F. Hoffmann-La Roche Ltd
- Sanofi S.A.
- Qiagen NV
Sun Pharmaceutical Industries Ltd
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Skin Cancer Market - By Cancer Type
1.3.2 Skin Cancer Market - By Type
1.3.3 Skin Cancer Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. SKIN CANCER MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. SKIN CANCER MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. SKIN CANCER MARKET - GLOBAL MARKET ANALYSIS
6.1. SKIN CANCER - GLOBAL MARKET OVERVIEW
6.2. SKIN CANCER - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. SKIN CANCER MARKET - REVENUE AND FORECASTS TO 2028 - CANCER TYPE
7.1. OVERVIEW
7.2. CANCER TYPE MARKET FORECASTS AND ANALYSIS
7.3. MELANOMA
7.3.1. Overview
7.3.2. Melanoma Market Forecast and Analysis
7.4. NON-MELANOMA
7.4.1. Overview
7.4.2. Non-melanoma Market Forecast and Analysis
8. SKIN CANCER MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
8.1. OVERVIEW
8.2. TYPE MARKET FORECASTS AND ANALYSIS
8.3. DIAGNOSIS
8.3.1. Overview
8.3.2. Diagnosis Market Forecast and Analysis
8.3.3. Dermatoscopy Market
8.3.3.1. Overview
8.3.3.2. Dermatoscopy Market Forecast and Analysis
8.3.4. Biopsy Market
8.3.4.1. Overview
8.3.4.2. Biopsy Market Forecast and Analysis
8.3.5. Genetic Tests Market
8.3.5.1. Overview
8.3.5.2. Genetic Tests Market Forecast and Analysis
8.3.6. Others Market
8.3.6.1. Overview
8.3.6.2. Others Market Forecast and Analysis
8.4. THERAPEUTICS
8.4.1. Overview
8.4.2. Therapeutics Market Forecast and Analysis
8.4.3. Chemotherapy Market
8.4.3.1. Overview
8.4.3.2. Chemotherapy Market Forecast and Analysis
8.4.4. Immunotherapy Market
8.4.4.1. Overview
8.4.4.2. Immunotherapy Market Forecast and Analysis
8.4.5. Targeted Therapy Market
8.4.5.1. Overview
8.4.5.2. Targeted Therapy Market Forecast and Analysis
8.4.6. Others Market
8.4.6.1. Overview
8.4.6.2. Others Market Forecast and Analysis
9. SKIN CANCER MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Skin Cancer Market Overview
9.1.2 North America Skin Cancer Market Forecasts and Analysis
9.1.3 North America Skin Cancer Market Forecasts and Analysis - By Cancer Type
9.1.4 North America Skin Cancer Market Forecasts and Analysis - By Type
9.1.5 North America Skin Cancer Market Forecasts and Analysis - By Countries
9.1.5.1 United States Skin Cancer Market
9.1.5.1.1 United States Skin Cancer Market by Cancer Type
9.1.5.1.2 United States Skin Cancer Market by Type
9.1.5.2 Canada Skin Cancer Market
9.1.5.2.1 Canada Skin Cancer Market by Cancer Type
9.1.5.2.2 Canada Skin Cancer Market by Type
9.1.5.3 Mexico Skin Cancer Market
9.1.5.3.1 Mexico Skin Cancer Market by Cancer Type
9.1.5.3.2 Mexico Skin Cancer Market by Type
9.2. EUROPE
9.2.1 Europe Skin Cancer Market Overview
9.2.2 Europe Skin Cancer Market Forecasts and Analysis
9.2.3 Europe Skin Cancer Market Forecasts and Analysis - By Cancer Type
9.2.4 Europe Skin Cancer Market Forecasts and Analysis - By Type
9.2.5 Europe Skin Cancer Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Skin Cancer Market
9.2.5.1.1 Germany Skin Cancer Market by Cancer Type
9.2.5.1.2 Germany Skin Cancer Market by Type
9.2.5.2 France Skin Cancer Market
9.2.5.2.1 France Skin Cancer Market by Cancer Type
9.2.5.2.2 France Skin Cancer Market by Type
9.2.5.3 Italy Skin Cancer Market
9.2.5.3.1 Italy Skin Cancer Market by Cancer Type
9.2.5.3.2 Italy Skin Cancer Market by Type
9.2.5.4 Spain Skin Cancer Market
9.2.5.4.1 Spain Skin Cancer Market by Cancer Type
9.2.5.4.2 Spain Skin Cancer Market by Type
9.2.5.5 United Kingdom Skin Cancer Market
9.2.5.5.1 United Kingdom Skin Cancer Market by Cancer Type
9.2.5.5.2 United Kingdom Skin Cancer Market by Type
9.2.5.6 Rest of Europe Skin Cancer Market
9.2.5.6.1 Rest of Europe Skin Cancer Market by Cancer Type
9.2.5.6.2 Rest of Europe Skin Cancer Market by Type
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Skin Cancer Market Overview
9.3.2 Asia-Pacific Skin Cancer Market Forecasts and Analysis
9.3.3 Asia-Pacific Skin Cancer Market Forecasts and Analysis - By Cancer Type
9.3.4 Asia-Pacific Skin Cancer Market Forecasts and Analysis - By Type
9.3.5 Asia-Pacific Skin Cancer Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Skin Cancer Market
9.3.5.1.1 Australia Skin Cancer Market by Cancer Type
9.3.5.1.2 Australia Skin Cancer Market by Type
9.3.5.2 China Skin Cancer Market
9.3.5.2.1 China Skin Cancer Market by Cancer Type
9.3.5.2.2 China Skin Cancer Market by Type
9.3.5.3 India Skin Cancer Market
9.3.5.3.1 India Skin Cancer Market by Cancer Type
9.3.5.3.2 India Skin Cancer Market by Type
9.3.5.4 Japan Skin Cancer Market
9.3.5.4.1 Japan Skin Cancer Market by Cancer Type
9.3.5.4.2 Japan Skin Cancer Market by Type
9.3.5.5 South Korea Skin Cancer Market
9.3.5.5.1 South Korea Skin Cancer Market by Cancer Type
9.3.5.5.2 South Korea Skin Cancer Market by Type
9.3.5.6 Rest of Asia-Pacific Skin Cancer Market
9.3.5.6.1 Rest of Asia-Pacific Skin Cancer Market by Cancer Type
9.3.5.6.2 Rest of Asia-Pacific Skin Cancer Market by Type
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Skin Cancer Market Overview
9.4.2 Middle East and Africa Skin Cancer Market Forecasts and Analysis
9.4.3 Middle East and Africa Skin Cancer Market Forecasts and Analysis - By Cancer Type
9.4.4 Middle East and Africa Skin Cancer Market Forecasts and Analysis - By Type
9.4.5 Middle East and Africa Skin Cancer Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Skin Cancer Market
9.4.5.1.1 South Africa Skin Cancer Market by Cancer Type
9.4.5.1.2 South Africa Skin Cancer Market by Type
9.4.5.2 Saudi Arabia Skin Cancer Market
9.4.5.2.1 Saudi Arabia Skin Cancer Market by Cancer Type
9.4.5.2.2 Saudi Arabia Skin Cancer Market by Type
9.4.5.3 U.A.E Skin Cancer Market
9.4.5.3.1 U.A.E Skin Cancer Market by Cancer Type
9.4.5.3.2 U.A.E Skin Cancer Market by Type
9.4.5.4 Rest of Middle East and Africa Skin Cancer Market
9.4.5.4.1 Rest of Middle East and Africa Skin Cancer Market by Cancer Type
9.4.5.4.2 Rest of Middle East and Africa Skin Cancer Market by Type
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Skin Cancer Market Overview
9.5.2 South and Central America Skin Cancer Market Forecasts and Analysis
9.5.3 South and Central America Skin Cancer Market Forecasts and Analysis - By Cancer Type
9.5.4 South and Central America Skin Cancer Market Forecasts and Analysis - By Type
9.5.5 South and Central America Skin Cancer Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Skin Cancer Market
9.5.5.1.1 Brazil Skin Cancer Market by Cancer Type
9.5.5.1.2 Brazil Skin Cancer Market by Type
9.5.5.2 Argentina Skin Cancer Market
9.5.5.2.1 Argentina Skin Cancer Market by Cancer Type
9.5.5.2.2 Argentina Skin Cancer Market by Type
9.5.5.3 Rest of South and Central America Skin Cancer Market
9.5.5.3.1 Rest of South and Central America Skin Cancer Market by Cancer Type
9.5.5.3.2 Rest of South and Central America Skin Cancer Market by Type
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL SKIN CANCER MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Middle East and Africa
10.5 South and Central America
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. SKIN CANCER MARKET, KEY COMPANY PROFILES
12.1. PFIZER INC.
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. BRISTOL-MYERS SQUIBB COMPANY
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ABBOTT LABORATORIES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. AMGEN, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MERCK AND CO., INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. NOVARTIS AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. F. HOFFMANN-LA ROCHE LTD
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SANOFI S.A.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. QIAGEN NV
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. SUN PHARMACEUTICAL INDUSTRIES LTD
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Pfizer Inc.
2. Bristol-Myers Squibb Company
3. Abbott Laboratories
4. Amgen, Inc.
5. Merck & Co., Inc.
6. Novartis AG
7. F. Hoffmann-La Roche Ltd
8. Sanofi S.A.
9. Qiagen NV
10. Sun Pharmaceutical Industries Ltd
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For